🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Tesla, Alibaba, Abercrombie & Fitch rise premarket; Lululemon falls

Published 01/09/2023, 09:14 PM
© Reuters.
GS
-
MA
-
ANF
-
V
-
TSLA
-
LULU
-
AZN
-
BABA
-
MRNA
-
UBER
-
CINC
-

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Monday, January 9th. Please refresh for updates.

  • Tesla (NASDAQ:TSLA) stock rose 3.5% after the electric car manufacturer signaled longer waiting times for potential buyers of some versions of the Model Y in China, suggesting increased demand after recently announced price cuts.

  • CinCor Pharma (NASDAQ:CINC) stock rose 133% after AstraZeneca (NASDAQ:AZN) agreed to acquire the U.S. biotech in a deal worth as much as $1.8 billion, as the Anglo-Swedish drugmaker looks to expand its pipeline of treatments for heart and kidney disorders.

  • Alibaba (NYSE:BABA) ADRs rose 4.9% on news that Ant Group's founder Jack Ma will give up control of the Chinese fintech giant in an overhaul, potentially easing government scrutiny.

  • Visa (NYSE:V) stock rose 1.2% and Mastercard (NYSE:MA) stock climbed 1.7% after KeyBanc upgraded its stance on the credit card giants, both to ‘overweight’ from ‘sector weight’, expecting them to outperform again in 2023.

  • Goldman Sachs (NYSE:GS) stock rose 0.3% after Bloomberg reported the investment bank was preparing its biggest round of job cuts since 2009 after over-hiring during the pandemic.

  • Moderna (NASDAQ:MRNA) stock rose 0.4% after the drugmaker stated it generated about $18.4B in COVID-19 vaccine sales in 2022.
  • Abercrombie & Fitch (NYSE:ANF) stock rose 4.3% after the clothing retailer raised its forecast for holiday-quarter sales, citing strong demand across its brands during the peak holiday selling period.
  • Lululemon Athletica (NASDAQ:LULU) stock fell 10% after the retailer said it expects holiday quarter gross margins to decline as it grapples with increased costs amid a drop in consumer spending.
  • Uber Technologies (NYSE:UBER) stock rose 2.8% after Piper Sandler upgraded its stance on the ride hailing firm to 'overweight' from 'neutral', saying rising car prices will boost demand for ride hailing.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.